Codes / ICD10CM / T57.2X4A

T57.2X4A Toxic effect of manganese and its compounds, undetermined, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic effect of manganese and its compounds, undetermined, initial encounter

Summary

This condition describes adverse health effects from exposure to manganese or its compounds, where the intent of exposure is unspecified. Manganese is a naturally occurring element, and its compounds can cause toxicity depending on dose, form, and route of exposure. Toxicity may affect multiple organ systems, including the nervous, respiratory, and hepatic systems, with symptoms ranging from mild to severe.

Causes

Toxic effects occur when the body is exposed to manganese or its compounds through inhalation, ingestion, or dermal contact. Common sources include industrial processes (e.g., welding, mining), contaminated water or soil, or handling of manganese-containing products. The severity of toxicity depends on the compound's properties, dose, and duration of exposure.

Risk Factors

  • Occupational exposure in industries such as welding, mining, or battery manufacturing.
  • Residing in areas with high environmental manganese levels in air or water.
  • Accidental or intentional handling of manganese-containing products.
  • Lack of proper safety measures during handling of hazardous materials.
  • Chronic exposure in settings with poor ventilation or inadequate protective equipment.

Symptoms

  • Neurological: Tremors, muscle rigidity, gait disturbances, or cognitive impairment.
  • Respiratory: Coughing, shortness of breath, or bronchitis.
  • Hepatic: Abdominal pain, jaundice, or liver dysfunction.
  • Other: Fatigue, headache, or mood changes.

Diagnosis

Diagnosis involves a thorough clinical evaluation, including a detailed exposure history and physical examination. Laboratory tests may assess manganese levels in blood, urine, or hair. Imaging studies (e.g., MRI) can evaluate neurological involvement. Differential diagnosis excludes other toxic exposures or neurological conditions.

Treatment Options

Treatment focuses on removing the source of exposure and managing symptoms. Chelation therapy may be considered in severe cases. Supportive care includes monitoring organ function, managing neurological symptoms, and providing respiratory support if needed. Long-term follow-up is often required.

Prognosis and Follow-Up

Prognosis depends on the extent of exposure and organ involvement. Early intervention improves outcomes, but chronic exposure may lead to persistent neurological effects. Follow-up includes regular monitoring of symptoms, organ function, and exposure reduction measures.

Complications

Potential complications include permanent neurological damage, respiratory failure, liver injury, or chronic kidney disease. Severe cases may require long-term disability support.

Lifestyle & Prevention

  • Avoid or limit exposure to manganese-containing environments.
  • Use protective equipment (e.g., masks, gloves) in occupational settings.
  • Ensure proper ventilation in industrial or home settings.
  • Test water or soil for manganese levels in high-risk areas.
  • Educate on safe handling of manganese-containing products.

When to Seek Professional Help

Seek immediate medical attention if exposure is suspected, especially with symptoms like severe neurological changes, respiratory distress, or abdominal pain. Prompt evaluation is critical for managing toxicity.

Tips for Medical Coders

Document the encounter type (initial) and specify that the intent of exposure is undetermined. Include details on exposure history, clinical findings, and treatment provided. Ensure the code aligns with the clinical scenario and documentation.

Book a walkthrough

T57.2X4A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.